The results of this study emphasize the importance of not solely relying on individual biomarkers such as CRP and ESR but rather incorporating a multidimensional assessment that considers various clinical, laboratory and radiological parameters to provide a more accurate risk assessment and guide treatment decisions for patients with PJI [26]. This evidence concerns the gene ESR1 and juvenile polyposis syndrome.